Moderna Teases Game-Changing Personalized mRNA Cancer Vaccine

Biotech titan Moderna has reported that its personalized cancer vaccine candidate has passed through a highly promising mid-stage study of skin cancer patients, driving home that its messenger RNA tech is indeed capable of revolutionary achievements...